Bayer has bolstered its cell and gene therapy ... modifying cells outside the body (ex vivo), which are reinfused to treat a disease – or directly administered (in vivo) to target tissues ...

(Bloomberg) -- Bayer AG’s kidney drug Kerendia helped patients avoid complications from a common form of heart failure in a ...